Skip to search
Skip to main content
Back to Search
Start Over
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
Authors :
Blach, Sarah Zeuzem, Stefan Manns, Michael Altraif, Ibrahim Duberg, Ann-Sofi Muljono, David H Waked, Imam Alavian, Seyed M Lee, Mei-Hsuan Negro, Francesco Abaalkhail, Faisal Abdou, Ahmed Abdulla, Maheeba Rached, Antoine Abou Aho, Inka Akarca, Ulus Al Ghazzawi, Imad Al Kaabi, Saad Al Lawati, Faryal Al Namaani, Khalid Al Serkal, Youssif Al-Busafi, Said A Al-Dabal, Layla Aleman, Soo Alghamdi, Abdullah S Aljumah, Abdulrahman A Al-Romaihi, Hamad E Andersson, Monique I Arendt, Vic Arkkila, Perttu Assiri, Abdullah M Baatarkhuu, Oidov Bane, Abate Ben-Ari, Ziv Bergin, Colm Bessone, Fernando Bihl, Florian Bizri, Abdul R Blachier, Martin Blasco, Antonio J Mello, Carlos E Brandão Bruggmann, Philip Brunton, Cheryl R Calinas, Filipe Chan, Henry L Y Chaudhry, Asad Cheinquer, Hugo Chen, Chien-Jen Chien, Rong-Nan Choi, Moon Seok Christensen, Peer B Chuang, Wan-Long Chulanov, Vladimir Cisneros, Laura Clausen, Mette R Cramp, Matthew E Craxi, Antonio Croes, Esther A Dalgard, Olav Daruich, Jorge R de Ledinghen, Victor Dore, Gregory J El-Sayed, Manal H Ergör, Gul Esmat, Gamal Estes, Chris Falconer, Karolin Farag, Elmoubashar Ferraz, Maria L G Ferreira, Paulo R Flisiak, Robert Frankova, Sona Gamkrelidze, Ivane Gane, Ed García-Samaniego, Javier Khan, Amir Ghafoor Gountas, Ilias Goldis, Adrian Gottfredsson, Magnús Grebely, Jason Gschwantler, Michael Pessôa, Mário Guimarães Gunter, Jessie Hajarizadeh, Behzad Hajelssedig, Omer Hamid, Saeed Hamoudi, Waseem Hatzakis, Angelos Himatt, Sayed M Hofer, Harald Hrstic, Irena Hui, Yee-Tak Hunyady, Bela Idilman, Ramazan Jafri, Wasim Jahis, Rohani Janjua, Naveed Z Jarčuška, Peter Jeruma, Agita Jonasson, Jón G Kamel, Yasser Kao, Jia-Horng Kaymakoglu, Sabahattin Kershenobich, David Khamis, Jawad Kim, Young S Kondili, Loreta Koutoubi, Zaher Krajden, Mel Krarup, Henrik Lai, Moon-sing Laleman, Wim Lao, Wai-cheung Lavanchy, Daniel Lázaro, Pablo Leleu, Henri Lesi, Olufunmilayo Lesmana, Laurentius A Li, Michael Liakina, Valentina Lim, Young-Suk Luksic, Boris Mahomed, Adam Maimets, Matti Makara, Mihály Malu, Abraham O Marinho, Rui T Marotta, Paul Mauss, Stefan Memon, Muhammad S Correa, Maria C Mendes Mendez-Sanchez, Nahum Merat, Shahin Metwally, Ammal M Mohamed, Rosmawati Moreno, Christophe Mourad, Fadi H Müllhaupt, Beat Murphy, Kimberly Nde, Helen Njouom, Richard Nonkovic, Diana Norris, Suzanne Obekpa, Solomon Oguche, Stephen Olafsson, Sigurður Oltman, Marian Omede, Ogu Omuemu, Casimir Opare-Sem, Ohene Øvrehus, Anne L H Owusu-Ofori, Shirley Oyunsuren, Tsendsuren S Papatheodoridis, George Pasini, Ken Peltekian, Kevork M Phillips, Richard O Pimenov, Nikolay Poustchi, Hossein Prabdial-Sing, Nishi Qureshi, Huma Ramji, Alnoor Razavi-Shearer, Devin Razavi-Shearer, Kathryn Redae, Berhane Reesink, Henk W Ridruejo, Ezequiel Robbins, Sarah Roberts, Lewis R Roberts, Stuart K Rosenberg, William M Roudot-Thoraval, Françoise Ryder, Stephen D Safadi, Rifaat Sagalova, Olga Salupere, Riina Sanai, Faisal M Avila, Juan F Sanchez Saraswat, Vivek Sarmento-Castro, Rui Sarrazin, Christoph Schmelzer, Jonathan D Schréter, Ivan Seguin-Devaux, Carole Shah, Samir R Sharara, Ala I Sharma, Manik Shevaldin, Anatoly Shiha, Gamal E Sievert, William Sonderup, Mark Souliotis, Kyriakos Speiciene, Danute Sperl, Jan Stärkel, Peter Stauber, Rudolf E Stedman, Catherine Struck, Daniel Su, Tung-Hung Sypsa, Vana Tan, Soek-Siam Tanaka, Junko Thompson, Alexander J Tolmane, Ieva Tomasiewicz, Krzysztof Valantinas, Jonas Van Damme, Pierre van der Meer, Adriaan J van Thiel, Ingo Van Vlierberghe, Hans Vince, Adriana Vogel, Wolfgang Wedemeyer, Heiner Weis, Nina Wong, Vincent WS Yaghi, Cesar Yosry, Ayman Yuen, Man-fung Yunihastuti, Evy Yusuf, Aasim Zuckerman, Eli Razavi, Homie
Source :
The Lancet Gastroenterology & Hepatology; March 2017, Vol. 2 Issue: 3 p161-176, 16p
Publication Year :
2017
Abstract
The 69th World Health Assembly approved the Global Health Sector Strategy to eliminate hepatitis C virus (HCV) infection by 2030, which can become a reality with the recent launch of direct acting antiviral therapies. Reliable disease burden estimates are required for national strategies. This analysis estimates the global prevalence of viraemic HCV at the end of 2015, an update of—and expansion on—the 2014 analysis, which reported 80 million (95% CI 64–103) viraemic infections in 2013.
Details
Language :
English
ISSN :
24681253
Volume :
2
Issue :
3
Database :
Supplemental Index
Journal :
The Lancet Gastroenterology & Hepatology
Publication Type :
Periodical
Accession number :
ejs40814879
Full Text :
https://doi.org/10.1016/S2468-1253(16)30181-9